Skip to Content

LBH 20 mg (Farydak 20 mg)

Generic Name: panobinostat

Pill with imprint LBH 20 mg is Red, Capsule-shape and has been identified as Farydak 20 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Farydak is used in the treatment of multiple myeloma and belongs to the drug class histone deacetylase inhibitors. Farydak 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LBH 20 mg

Farydak 20 mg LBH 20 mg

Farydak

Generic Name
panobinostat
Imprint
LBH 20 mg
Strength
20 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Histone deacetylase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0652

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.